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Background & Objectives: The aim of our study was to characterise
megakaryocytes and platelets variation under the influence of heavy metal
salts and determine the peculiarities of these changes in recovery period.
Methods: The laboratory rats (n=48) were used for the conduction of
experimental investigation. They were divided into two groups: control –
animals which drank cleanwater and experimental – rats which drankwater
with heavy metal salts (Zn, Cu, Fe, Mn, Cr and Pb). The bone marrow
structure and blood parameters were studied on 30, 90, 120 and 180 day.
Results: During 90 days of intoxication the amount of megakaryocytes
increased on 40%(р=0.017). There were changes of shape, size (small
and giant), nuclear-cytoplasmic ratio, polysegmentation of nuclei and loss
of megakaryocyte-sinusoid contacts. It was found the platelets increase
by 11% in the blood. Suspending the addition of pollutants to the animal's
diet was accompanied by progressive restoration of bone marrow-blood
parameters. Simultaneously with disappearance of megakaryocytes mor-
phological variations the area of thrombocytopoiesis was decreased by
28%, the thrombocytes – by 5.3%.
Conclusion: The intake of heavy metal salts in elevated concentrations
provokes significant disorders in thrombocytopoiesis which leads for
platelets increase in the blood. Although there was a significant improve-
ment bone marrow-blood characteristics during recovery period, their
values do not reach the indicators of the intact group animals.
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Background&Objectives:Myeloid/lymphoid neoplasms (MLNs) with
eosinophilia and gene rearrangement are rare diseases characterised by
myeloid and/or lymphoid proliferation, eosinophilia, and a fusion gene
with constitutive tyrosine kinase (TK) activity. These disorders are re-
sponsive to TK inhibitors (TKIs) excluding FGFR1-rearranged MLNs,
for which there is currently no standardised therapy.
The aim of this study is to report 7 cases of MLNs collected from 2003 to
2018.
Methods:All patients underwent bone marrow (BM) core biopsy that
showed hypercellular BM, hyperplasia of eosinophilic granulopoiesis
and features of myeloproliferative neoplasms (MPNs). In 4 out of 7
patients with lymphadenopathy, excisional lymph node biopsy was
performed revealing a T-lymphoblastic lymphoma (T-LBL). Gene
rearrangement was assessed with cytogenetic and/or molecular
analysis.
Results: In 6 out of 7 cases, the fusion gene has been identified: FIP1L1-
PDGFRA (2/7), ETV6-PDGFRB (2/7) and ZMYM2-FGFR1 (2/7). In
one case, no currently known TK fusion genes were recognized.
Two PDGFRA-rearranged patients (one with MPN+T-LBL), two
PDGFRB-rearranged patients, one FGFR1-rearranged patient (MPN+T-
LBL) and the one with unidentified rearrangement (MPN+T-LBL) were
treated with imatinib: all achieved complete hematologic remission ex-
cept the FGFR1-rearranged patient.
The other FGFR1-rearranged patient (MPN+T-LBL) was treated with
polychemotherapy and allogeneic transplantation followed by relapse.
Conclusion: Our cases confirm responsiveness of PDGFRA/B-
rearranged MLNs to imatinib and possible existence of not yet known
fusion TKs, which may benefit from TKIs. Identification of LBL in
MLNs avoids overtreatment/nonresponse to intensive chemotherapy rec-
ommended in LBL.
FGFR1-rearranged MLNs exhibit poor prognosis without an effective
targeted treatment. Recently, pemigatinib, a selective, potent inhibitor of
FGFR1, has shown promising results.
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Background&Objectives: Classical Hodgkin lymphoma (cHL) is highly
curable, however relapse still occurs in up to 30% of (advanced) cHL cases.
Case reports and small series have shown that some of these relapses appear
to be a new primary cHL. Conventional clonality assays for cHL has thus far
been hampered by low frequencies of Hodgkin and Reed-Sternberg cells
and limited DNA quality obtained from formalin-fixed paraffin-embedded
tissues. Within the EuroClonality-NGS Working Group, we developed a
novel approach to detect immunoglobulin heavy chain (IGH) and k light
chain (IGK) gene rearrangements. The objective of our study is to determine
the clonal relationship between diagnosis and recurrent cHL to assess the
incidence of second primary malignancies.
Methods:We collected 70 paired diagnosis-recurrence cHL cases includ-
ing early and late recurrences. Gene-specific IGH-VJ-FR3, IGHDJ, IGK-
VJ and Intron-Kde primer sets were used to perform next-generation
sequencing (NGS)-based clonality analysis with Ion Torrent PGM.
Bioinformatics analysis is performed with the interactive web-based
immunoprofiler ARResT/Interrogate.
Results: Preliminary results of 7 paired diagnosis-relapse samples dem-
onstrates the presence of identical clonotypes in 2 cases, while distinct
clonotypes were observed in 3 other cases suggesting a second primary
lymphoma. No specific clonotype were identified in either diagnosis and/
or relapse of the remaining 2 samples. Additional cases of recurrent cHL
have to be analysed to reveal the true incidence of clonally unrelated
lymphomas in recurrent cHL.
Conclusion: This study is an important step towards establishment of
NGS-based clonality assessment in clinical practice for cHL, and even-
tually the improvement of therapeutic management of recurrent cHL.
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Background & Objectives: Composite lymphomas are rare entities in
which two or more different lymphomas coexist in the same site. Little is
known about their clinical and prognostic implications. We present a
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